Dr. Chelsea Cooper, M.D.
Dermatology
9+
Years in Practice
Practice Locations
1 location
About Dr. Chelsea Cooper
Chelsea Cooper, MD is a healthcare provider.
Specialty Definition
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
9
Years Experience
1
Location
2
States Licensed
Credentials & Board Certifications
Additional Specialties
Primary Specialty
DermatologyCredentials verified via NPI Registry (NPPES)
Education & Training
Medical School
Georgetown University School Of Medicine
Class of 2017
Licenses & Practice States
Licensed in 2 states
| State | License | Classification | Primary |
|---|---|---|---|
| — | Student in an Organized Health Care Education/Training Program | — | |
| New Jersey | 25MA11211800 | Dermatology |
Public Data Summary for Dr. Chelsea Cooper
In their first decade of practice, Dr. Chelsea Cooper represents the newer generation of dermatology providers, M.D., after earning their medical degree at Georgetown University School Of Medicine in 2017. Dr. currently practices at in Red Bank, New Jersey. Their National Provider Identifier (NPI) is 1407389745, and the profile below combines data from CMS NPPES, Medicare billing records, the HHS OIG exclusion list, and — where available — CMS Open Payments, Medicare Utilization, and Part D prescriber summaries.
CMS Medicare data shows Dr. Chelsea Cooper as a lower-volume dermatology provider, treating approximately 288 Medicare beneficiaries and delivering 2K services in the most recent reporting year. That panel size indicates a smaller, more selective practice pattern.
Under the Physician Payments Sunshine Act, CMS reports that Dr. Chelsea Cooper received $311 in industry payments in 2023. Payments at this scale are typical for most practicing physicians and generally reflect routine educational activities.
Transparency & Safety
Public records from CMS and OIG databases
Industry Payments
$311
Total payments received from pharmaceutical and medical device companies in 2023.
Source: CMS Open Payments (Sunshine Act)
Opioid Prescribing
This provider has no opioid prescriptions on file in Medicare Part D data.
Insurance & Accessibility
Reviews
Community reviews for Dr. Chelsea Cooper
--
0 reviews
Dermatology Providers Nearby
Same primary specialty near ZIP 07701
FAQ
Frequently asked questions about Dr. Chelsea Cooper
What does Dr. Chelsea Cooper specialize in?
Dr. Chelsea Cooper specializes in Dermatology. Secondary taxonomy filings also list Student In An Organized Health Care Education/training Program.
Where does Dr. Chelsea Cooper practice?
Dr. Chelsea Cooper practices at in Red Bank, New Jersey.
Does Dr. Chelsea Cooper accept Medicare?
CMS records show that Dr. Chelsea Cooper accepts Medicare assignment. CMS billing data shows 288 Medicare beneficiaries treated in the most recent reporting year.
What is Dr. Chelsea Cooper's NPI number?
Dr. Chelsea Cooper's National Provider Identifier (NPI) is 1407389745. This is the unique 10-digit number the Centers for Medicare & Medicaid Services assigns to every practicing US healthcare provider. You can verify this number directly at the NPPES NPI Registry.
How long has Dr. Chelsea Cooper been practicing?
Dr. Chelsea Cooper has approximately 9 years of practice experience, having graduated from Georgetown University School Of Medicine in 2017.